SANTHERA PHARMACEUTICALS HOLDING AGSANTHERA PHARMACEUTICALS HOLDING AGSANTHERA PHARMACEUTICALS HOLDING AG

SANTHERA PHARMACEUTICALS HOLDING AG

No trades
See on Supercharts
Next report date
Report period
H1 2024
EPS estimate
Revenue estimate
Market capitalization
‪89.75 M‬USD
‪65.07 M‬USD
‪122.78 M‬USD
‪7.06 M‬
Beta (1Y)
−1.01

About SANTHERA N

CEO
Dario Eklund
Headquarters
Pratteln
Founded
1998
ISIN
CH1276028821
FIGI
BBG000RRKS06
Santhera Pharmaceuticals Holding AG engages in the development and commercialization of products for the treatment of neuromuscular and pulmonary diseases. Its product pipeline includes Vamorolone and Lonodelestat. The company was founded by Thomas Meier in 1998 and is headquartered in Pratteln, Switzerland.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of SPHDF is 11.70 USD — it has increased by 4.00% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange SANTHERA PHARMACEUTICALS HOLDING AG stocks are traded under the ticker SPHDF.
SANTHERA PHARMACEUTICALS HOLDING AG is going to release the next earnings report on Sep 4, 2024. Keep track of upcoming events with our Earnings Calendar.
SPHDF stock is 3.85% volatile and has beta coefficient of −1.01. Check out the list of the most volatile stocks — is SANTHERA PHARMACEUTICALS HOLDING AG there?
Yes, you can track SANTHERA PHARMACEUTICALS HOLDING AG financials in yearly and quarterly reports right on TradingView.
SPHDF net income for the last quarter is ‪92.78 M‬ USD, while the quarter before that showed ‪−26.06 M‬ USD of net income which accounts for 456.05% change. Track more SANTHERA PHARMACEUTICALS HOLDING AG financial stats to get the full picture.
Today SANTHERA PHARMACEUTICALS HOLDING AG has the market capitalization of ‪113.83 M‬, it has increased by 1.63% over the last week.
No, SPHDF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, SPHDF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SANTHERA PHARMACEUTICALS HOLDING AG stock right from TradingView charts — choose your broker and connect to your account.
SPHDF reached its all-time high on Sep 21, 2015 with the price of 1371.50 USD, and its all-time low was 6.80 USD and was reached on Apr 3, 2023.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SANTHERA PHARMACEUTICALS HOLDING AG technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SANTHERA PHARMACEUTICALS HOLDING AG stock shows the sell signal. See more of SANTHERA PHARMACEUTICALS HOLDING AG technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on SANTHERA PHARMACEUTICALS HOLDING AG future price: according to them, SPHDF price has a max estimate of 33.95 USD and a min estimate of 14.71 USD. Read a more detailed SANTHERA PHARMACEUTICALS HOLDING AG forecast: see what analysts think of SANTHERA PHARMACEUTICALS HOLDING AG and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SANTHERA PHARMACEUTICALS HOLDING AG EBITDA is ‪63.59 M‬ USD, and current EBITDA margin is 51.79%. See more stats in SANTHERA PHARMACEUTICALS HOLDING AG financial statements.